Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Procter & Gamble Likely To Report Higher Q1 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Published 18/10/2023, 07:56
Updated 18/10/2023, 09:10
© Reuters.  Procter & Gamble Likely To Report Higher Q1 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Benzinga - by Lisa Levin, Benzinga Editor.

The Procter & Gamble Company (NYSE: PG) is expected to release financial results for its first quarter, before the opening bell on Oct. 18, 2023.

Analysts expect the company to post quarterly earnings at $1.63 per share, up from year-ago earnings of $1.57 per share. The company’s revenue might come in at $20.51 billion, compared to $20.33 billion in the year-ago period.

Procter & Gamble shares gained 0.1% to close at $146.26 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Stifel analyst Mark Astrachan maintained a Hold rating and cut the price target from $161 to $151 on Oct. 16, 2023. This analyst has an accuracy rate of 82%.
  • Barclays analyst Lauren Lieberman maintained an Overweight rating and lowered the price target from $166 to $154 on Oct. 12, 2023. This analyst has an accuracy rate of 60%.
  • Bernstein analyst Callum Elliott maintained a Market Perform rating and cut the price target from $162 to $153 on Oct. 12, 2023. This analyst has an accuracy rate of 60%.
  • Morgan Stanley analyst Dara Mohsenian reiterated an Overweight rating with a price target of $174 on Aug. 1, 2023. This analyst has an accuracy rate of 70%.
  • B of A Securities analyst Olivia Tong maintained a Buy rating and raised the price target from $170 to $175 on Aug. 1, 2023. This analyst has an accuracy rate of 66%.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read This Next: Top 3 Health Care Stocks That May Implode This Quarter

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.